Quinine Sulfate Market Report 2025

This Quinine Sulfate market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The quinine sulfate market size has grown strongly in recent years. It will grow from $2.41 billion in 2024 to $2.62 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to increasing malaria prevalence, demand for anti-malarial treatments, rising pharmaceutical manufacturing, growing awareness of quinine's therapeutic uses, and rising demand in tropical regions.

The quinine sulfate market size is expected to see strong growth in the next few years. It will grow to $3.6 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing focus on tropical disease treatment, rising healthcare expenditure in developing nations, demand for muscle relaxant medications, growing population in malaria-endemic areas, and improving the supply chain for raw materials. Major trends in the forecast period include increasing demand for generic anti-malarial drugs, rising investment in healthcare in emerging markets, technological integration in pharmaceutical production, growing regulatory emphasis on drug safety, and increased global focus on malaria eradication strategies.

The rising incidence of malaria is projected to significantly drive the growth of the quinine sulfate market in the coming years. Malaria is a life-threatening infectious disease caused by Plasmodium parasites, transmitted to humans through the bites of infected female Anopheles mosquitoes, leading to symptoms such as fever, chills, and flu-like illness. The increasing malaria cases can be attributed to several factors, including the emergence of drug-resistant strains, the expansion of mosquito habitats due to climate change, and inadequate healthcare access. Quinine sulfate is utilized in the treatment of malaria by targeting and killing the Plasmodium parasites responsible for the infection. It disrupts the parasite’s ability to grow and reproduce within red blood cells. For instance, in October 2023, the World Health Organization (WHO) reported in its World Malaria Report 2023 that approximately 249 million malaria cases were documented globally in 2022 across 85 endemic countries, reflecting a 5 million increase from 2021. Thus, the growing incidence of malaria is a key driver of the quinine sulfate market.

The increasing consumer interest in natural and organic products is expected to further stimulate growth in the quinine sulfate market. This trend is driven by heightened awareness of health benefits, environmental sustainability, ethical sourcing, a preference for products free from synthetic additives and chemicals, and concerns regarding long-term wellness and ecological impact. Quinine sulfate aligns with this trend by offering a plant-based alternative derived from cinchona bark, catering to consumer preferences for traditional herbal remedies and natural ingredients in wellness and medicinal applications. For example, a report published in May 2024 by the Organic Trade Association (OTA) highlighted that US sales of certified organic products approached $70 billion in 2023, with dollar sales reaching $69.7 billion, marking a 3.4 percent increase from 2022. Therefore, the growing interest in natural and organic products is positively influencing the quinine sulfate market.

Key players in the quinine sulfate market are focusing on developing innovative solutions, such as the efficient synthesis of quinine and its derivatives, to optimize the production process, reduce time, waste, and costs, while enhancing chemical synthesis capabilities. The synthesis of quinine sulfate involves laboratory chemical processes that replicate its natural extraction from the cinchona tree bark, facilitating large-scale production for malaria treatment. For instance, in December 2022, Tohoku University, a Japan-based research institution, achieved a significant breakthrough in the enantioselective synthesis of quinine. This research demonstrated an efficient one-pot synthesis of quinine and its derivatives, utilizing organ catalysts to streamline the process and minimize the number of steps required. This advancement is notable as it reduces chemical waste, shortens production time, and potentially lowers costs, thereby enabling the development of new medications and enhancing overall synthesis efficiency.

Major companies operating in the quinine sulfate market are Sanofi SA, Thermo Fisher Scientific Inc., Viatris Inc., Teva Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Dr. Reddy's Laboratories, Cipla Limited, Lupin Limited, Strides Pharma, Taj Pharmaceuticals, Wockhardt Ltd., Alchem International Private Limited, SimSon Pharma Limited, Hangzhou Dayang Co. Ltd., Haihang Industry Co. Ltd., Pharmakina SA, Aecochem Corp, Buchler GmbH, Prism Industries Private Limited, Shreeji Pharma International, Trademax Pharmaceuticals & Chemicals, Sihauli Chemicals Private Limited.

Asia-Pacific was the largest region in the quinine sulfate market in 2023. The regions covered in the quinine sulfate market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the quinine sulfate market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Quinine sulfate is a naturally derived alkaloid medication extracted from the bark of the cinchona tree, widely utilized in pharmaceutical formulations for its therapeutic effects. It is primarily indicated for the treatment of malaria and the relief of nocturnal leg cramps, owing to its capacity to disrupt the reproduction of malaria-causing parasites and relax muscle contractions.

The main dosages of quinine sulfate include 200 mg and 300 mg, with the 200 mg formulation specifically designed for treating conditions such as malaria, where each dose contains 200 milligrams of the active ingredient. Available product forms encompass quinine sulfate tablets, capsules, injections, powder, and oral solutions. These products are distributed through various channels, including hospitals, retail pharmacies, and online pharmacies. Quinine sulfate is applied in the treatment of malaria, problematic leg cramps, lupus, rheumatoid arthritis, among other conditions. Its end users include adults, pediatric patients, and geriatric populations.

The quinine sulfate market research report is one of a series of new reports that provides quinine sulfate market statistics, including quinine sulfate industry global market size, regional shares, competitors with a quinine sulfate market share, detailed quinine sulfate market segments, market trends and opportunities, and any further data you may need to thrive in the quinine sulfate industry. This quinine sulfate market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The quinine sulfate market consists of sales of quinine sulfate suspensions, quinine sulfate granules, quinine sulfate infusions, quinine sulfate suppositories, and quinine sulfate topical preparations. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.